Seeing Is Believing
Currently out of the existing stock ratings of Danielle Brill, 157 are a BUY (81.77%), 30 are a HOLD (15.63%), 5 are a SELL (2.6%).
Analyst Danielle Brill, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 47.28% that have a potential upside of 29.25% achieved within 152 days.
Danielle Brill’s has documented 360 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IRON, Disc Medicine at 11-Jun-2025.
Analyst best performing recommendations are on AGIO (AGIOS PHARM).
The best stock recommendation documented was for XLRN (ACCELERON PHARMA) at 1/8/2020. The price target of $73 was fulfilled within 20 days with a profit of $19.46 (36.35%) receiving and performance score of 18.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$37
$16.02 (76.36%)
$42
18 days ago
(25-Jun-2025)
9/16 (56.25%)
$14.79 (66.59%)
238
Buy
$32
$11.02 (52.53%)
$32
18 days ago
(25-Jun-2025)
7/23 (30.43%)
$9.79 (44.08%)
118
Buy
$30
$9.02 (42.99%)
$30
18 days ago
(25-Jun-2025)
0/9 (0%)
$7.79 (35.07%)
Hold
$22
$1.02 (4.86%)
$19
18 days ago
(25-Jun-2025)
16/16 (100%)
$-0.21 (-0.95%)
89
Buy
$30
$9.02 (42.99%)
$25
1 months 8 days ago
(05-Jun-2025)
5/9 (55.56%)
$8.02 (36.49%)
26
Which stock is Danielle Brill is most bullish on?
What Year was the first public recommendation made by Danielle Brill?